Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1ALDESLEUKIN
(Proleukin (TN))		[1] Aldesleukin (Proleukin)[1] Aldesleukin (Proleukin (TN)) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[4] 49, 65, 96, 97 💬
2Interleukin-2 (aldesleukin).
(Proleukin (TN))		[2] Aldesleukin (Proleukin),
Human interleukin-2		[1] Aldesleukin (Proleukin (TN)) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[2] 96, 97 💬
3Low-dose Aldesleukin (Proleukin®)[1] Aldesleukin (Proleukin)[1] Aldesleukin (Proleukin (TN)) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 49 💬
4Proleukin[1] Aldesleukin (Proleukin)[1] Aldesleukin (Proleukin (TN)) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[3] 2, 49, 65 💬
5Proleukin 18 MUI[1] Aldesleukin (Proleukin)[1] Aldesleukin (Proleukin (TN)) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 2 💬
6PROLEUKIN® S[1] Aldesleukin (Proleukin)[1] Aldesleukin (Proleukin (TN)) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 65 💬